These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2109430)

  • 21. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder.
    Peters MM; Rivera MI; Jones TW; Monks TJ; Lau SS
    Cancer Res; 1996 Mar; 56(5):1006-11. PubMed ID: 8640754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of nafimidone in rats.
    Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ
    Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes.
    Tajima K; Hashizaki M; Yamamoto K; Mizutani T
    Drug Metab Dispos; 1991; 19(6):1028-33. PubMed ID: 1687007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
    Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH; Jung BH; Chung BC; Park J; Mitoma C
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of oxidative stress in D-serine induced nephrotoxicity.
    Orozco-Ibarra M; Medina-Campos ON; Sánchez-González DJ; Martínez-Martínez CM; Floriano-Sánchez E; Santamaría A; Ramirez V; Bobadilla NA; Pedraza-Chaverri J
    Toxicology; 2007 Jan; 229(1-2):123-35. PubMed ID: 17110013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro uptake of methyl tert-butyl ether in male rat kidney: use of a two-compartment model to describe protein interactions.
    Poet TS; Borghoff SJ
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):340-8. PubMed ID: 9266807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
    Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
    Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.
    Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR
    Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of N-(2-propenal) serine as a urinary metabolite of malondialdehyde.
    Hadley M; Draper HH
    FASEB J; 1988 Feb; 2(2):138-40. PubMed ID: 3125082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection process of the tert-butyl group as a non-polar moiety of D-serine: unexpected rearrangement.
    Choi BE; Jeong JH
    Arch Pharm Res; 2000 Dec; 23(6):564-7. PubMed ID: 11156175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal disposition and nephrotoxicity of xenobiotics. Proceedings of the joint symposium of the Universities of Würzburg and Rochester. Würzburg, 7-10 October, 1990.
    Toxicol Lett; 1990 Sep; 53(1-2):1-261. PubMed ID: 2219146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.